Hub provides Focal Point for Investment and Growth

The BioHub Birmingham has provided the first physical footprint within the UK and Europe for Infectious disease diagnostics company Genetic Signatures, a provider of testing kits to countries in Europe and of clinical diagnostics to the NHS for respiratory and gastro-intestinal diseases and sexually transmitted infections.

The localisation of service and support has become a key focus for the company which will now include Field Applications Scientists at its site operations. The BioHub laboratory will support the development of protocols, processes and quality performance materials that are necessary for planned growth into new territories in Europe, the Middle East and Africa and also offer customers additional training and technical support opportunities through hands-on learning.

The team is led by Director John Buckels, an infectious diseases veteran who is already based in the UK. “Genetic Signatures has an established customer base in Europe and taking a physical base for these operations is showcasing the commitment of our investment for future growth in the region,” he said.

管理生物中心的组织伯明翰企业大学的首席执行官David Coleman评论说:“我们很高兴欢迎遗传签名加入伯明翰生物中心®。我们的设施和专业知识使我们的位置成为寻求进入英国市场的医疗保健和生命科学公司的理想目的地。我们是伯明翰健康合作伙伴在一个高度连接的生态系统中的一部分，该生态系统已被英国政府指定为生命科学机遇区，还包括定于2023年开放的精密健康技术加速器。”

More informationonline